| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 65,494 | 57,265 | 51,072 | 64,630 | | Cost of Revenue | 53,353 | 59,488 | 47,383 | 52,545 | | | Gross Profit | 12,141 | (2,223) | 3,689 | 12,085 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,416 | 8,336 | 8,040 | 8,813 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 422 | 410 | 386 | 393 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,303 | (10,969) | (4,737) | 2,879 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 965 | 293 | 115 | 376 | | Earnings Before Interest And Taxes | 4,268 | (10,676) | (4,622) | 3,255 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 4,268 | (10,676) | (4,622) | 3,255 | | Income Tax Expense | 1,323 | (3,944) | (1,448) | 983 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,945 | (6,732) | (3,174) | 2,272 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,945 | (6,732) | (3,174) | 2,272 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,945 | ($6,732) | ($3,174) | $2,272 |
|
0.29% Nasdaq 
0.14%
Income Statement
